Updated on 2026/07/14

写真a

 
Terasaki Mika
 
Affiliation
Faculty of Medicine, Department of Medicine, Department of Analytic Human Pathology, Associate Professor
Title
Associate Professor
Profile

臨床病理医として、AI技術の診断応用研究に取り組んでいます。当初は深層学習(DL)モデルの開発を行っていましたが、その過程で『判断根拠が不透明』というブラックボックス問題の臨床応用に潜む危険性を認識しました。現在は、主流のDLとは一線を画し、熟練病理医の診断思考を実装した『説明可能なルールベースAI』の開発に注力しています。高価なWSIを必要とせず、既存の顕微鏡で動作する本システムを通じて、医療資源が限られた環境でも利用可能な『医療AIの民主化』を目指します。

 

External link

Research Interests

  • Endometrial Cytology

  • Mathematical Modeling

  • Pathology Informatics

  • Real-time Diagnostic Support

  • WSI-free AI

  • Ethics in Medical AI

  • Explainable AI, XAI

  • Rule-based AI

Research Areas

  • Life Science / Human pathology  / Pathology Informatics / Real-time diagnostic support / Surgical pathology support / Endometrial cytology / WSI-free AI / Gynecologic pathology

  • Informatics / Intelligent informatics  / Explainable AI (XAI) / Rule-based AI / Ethics in medical AI / Mathematical modeling / AI-based pathological image analysis

Education

  • Kumamoto University   School of Medicine

    1999.4 - 2004.3

      More details

    Country: Japan

    researchmap

Research History

  • Nippon Medical School   Department of Analytic Human Pathology   Associate Professor

    2025.10

      More details

    Country:Japan

    researchmap

  • Nippon Medical School   Senior Assistant Professor

    2021.4

      More details

  • Nippon Medical School   Assistant Professor

    2010.5

      More details

  • 熊本大学医学部   細胞病理学分野   助教

    2005.4

      More details

Professional Memberships

▼display all

Papers

  • Development and Clinical Application of a Deep Learning-Based AI Support Model for Endometrial Cancer Cytology. Reviewed

    Ichito Shimokawa, Mika Terasaki, Shun Tanaka, Etsuko Toda, Shoichiro Takakuma, Yusuke Kajimoto, Shinobu Kunugi, Akira Shimizu, Yasuhiro Terasaki

    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi   93 ( 1 )   80 - 94   2026

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The global increase in endometrial cancer, including in Japan, and a shortage of pathologists and cytotechnologists have increased the diagnostic burden, emphasizing the need for an AI-based diagnostic support model that uses deep learning. We evaluated the clinical application of an improved AI-supported endometrial cytology model. METHODS: Using YOLOv5x and YOLOv7 models evaluated by mean average precision (mAP), we compared two datasets-one annotated for both benign and malignant cell clusters, and one for malignant only. In addition, using the Two One-Sided Tests (TOST) procedure, we assessed the correlation between AI diagnostic accuracy and the level of difficulty perceived by human diagnosticians. Finally, we used Gradient-weighted Class Activation Mapping (Grad-CAM) to visualize and enhance the interpretability of the AI model's decision-making process. RESULTS: The YOLOv5x model with both benign and malignant annotations had the highest malignant mAP, 0.798, as compared with YOLOv7. The TOST analysis showed no significant difference in perceived diagnostic difficulty between cases that were correctly and incorrectly diagnosed by the AI model, indicating consistent AI accuracy regardless of case difficulty. Grad-CAM visualizations clarified the AI model's decision-making basis; in some cases, the model appeared to focus on regions that differed from those typically attended to by human diagnosticians. CONCLUSION: The AI support model showed high and consistent accuracy in endometrial cytological analysis, regardless of diagnostic difficulty as perceived by human diagnosticians. Grad-CAM visualizations revealed diagnostic patterns, and the AI occasionally focused on regions different from those emphasized by human diagnosticians. This study advanced a real-time microscope-integrated AI system toward clinical application.

    DOI: 10.1272/jnms.JNMS.2026_93-115

    PubMed

    researchmap

  • An integrated system from microscopy to AI for real-time object detection in endometrial cytology Reviewed

    Mika Terasaki, Shun Tanaka, Ichito Shimokawa, Etsuko Toda, Shoichiro Takakuma, Yusuke Kajimoto, Shinobu Kunugi, Akira Shimizu, Yasuhiro Terasaki

    Journal of Pathology Informatics   in press   2025.12

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.jpi.2025.100541

    researchmap

  • Prognostic Significance of Actinin‐4 Protein Expression and Gene Amplification in Endometrial Carcinoma Reviewed

    Li Xiang, Yutaka Naito, Masafumi Toyoshima, Mika Terasaki, Akihito Yamamoto, Akira Shimizu, Shunji Suzuki, Kazufumi Honda

    Journal of Obstetrics and Gynaecology Research   2025.11

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/jog.70132

    researchmap

  • Diffuse pulmonary ossification and its association with cicatricial organising pneumonia in idiopathic and secondary forms. Reviewed International journal

    Yasuhiro Terasaki, Yasuhiko Nishioka, Yusuke Kajimoto, Yuko Toyoda, Akira Hebisawa, Takeshi Johkoh, Ryoko Egashira, Takeshi Hisada, Masamichi Mineshita, Tomohisa Baba, Yuji Fujikura, Motoyasu Kato, Kazuya Ichikado, Yoshikazu Inoue, Shinyu Izumi, Yoshinori Hasegawa, Tomohiro Handa, Koko Hidaka, Shu Hisata, Chisato Honjo, Takumi Kishimoto, Masaki Okamoto, Mari Yamasue, Mika Terasaki, Takafumi Suda

    Scientific reports   15 ( 1 )   12442 - 12442   2025.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Diffuse pulmonary ossification (DiPO) is characterised by widespread ectopic bone formation in the lungs. Idiopathic DiPO (I-DiPO) poses significant diagnostic challenges and its ossification mechanism remains unclear. Cicatricial organising pneumonia (CiOP) lesions form fibrous nodules without damaging lung structure. We investigated the histopathological features of I-DiPO, focusing on the surrounding fibrosis, and compared them with those of secondary DiPO (S-DiPO). An analysis was conducted using data from a nationwide DiPO survey in Japan. The dataset included clinical, radiological, and histopathological data of patients with suspected I-DiPO. The specific patterns of ossification and fibrotic findings such as CiOP, organising pneumonia (OP), and subpleural fibrosis were identified. Eighteen and seven patients were classified as having I-DiPO and S-DiPO, respectively. I-DiPO affects younger patients, progresses slowly, commonly occurs in the lower lungs, and has a lower mortality rate. S-DiPO affects older patients, presents with widespread lung lesions, and has a higher mortality rate. CiOP lesions were found in direct continuity with or near ossified lesions in 61.1% and 71.4% of patients with I-DiPO and S-DiPO, respectively. OP, CiOP, and ossified lesions often observed in the same locations in S-DiPO. DiPO has a unique pathogenesis, with an ossification transition occurring via the CiOP lesions. These findings provide valuable insights for future diagnostic approaches and management strategies for this condition.

    DOI: 10.1038/s41598-025-95307-0

    PubMed

    researchmap

  • Uterine carcinosarcoma showing immature teratoid-like differentiation. Reviewed International journal

    Mio Naito, Mika Terasaki, Nozomi Ouchi, Masafumi Toyoshima

    BMJ case reports   16 ( 12 )   2023.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A carcinosarcoma is a rare form of cancer characterised by the presence of both carcinomatous and sarcomatous components. Here, we present our experience with an extremely rare case of an uterine carcinosarcoma with immature teratoid-like differentiation. The patient was a woman in her 60s. She was referred for the evaluation of a uterine tumour. She underwent total abdominal hysterectomy with bilateral adnexectomy and received postoperative treatment with paclitaxel and carboplatin. On microscopic examination, the tumour had a heterogeneous appearance with a combination of carcinomatous and sarcomatous elements, and teratoid features. The tumour included immature squamous epithelial cells and immature epithelial glands, and focal atypical fused glands, which are consistent with endometrioid carcinoma, were identified in the endometrium. Pathological differentiation from extrarenal Wilms' tumour and teratocarcinosarcoma was challenging. The final pathological diagnosis was uterine carcinosarcoma with immature teratoid-like differentiation. At 14 months after the surgery, the patient has not experienced recurrence.

    DOI: 10.1136/bcr-2023-257228

    PubMed

    researchmap

  • 子宮内膜細胞診サポートAIモデルの開発 Invited

    寺崎美佳

    臨床婦人科産科   77 ( 12 )   1228 - 1233   2023.12

     More details

    Authorship:Lead author   Language:Japanese  

    DOI: 10.11477/mf.1409211112

    researchmap

  • Artificial Intelligence and Pathology Invited

    Mika Terasaki, Yasuhiro Terasaki, Akira Shimizu

    Nihon Ika Daigaku Igakkai Zasshi   19 ( 2 )   72 - 77   2023.4

     More details

    Authorship:Lead author   Language:Japanese   Publisher:Medical Association of Nippon Medical School  

    DOI: 10.1272/manms.19.72

    researchmap

  • Inhibition of the chemokine signal regulator FROUNT by disulfiram ameliorates crescentic glomerulonephritis. Reviewed International journal

    Etsuko Toda, Anri Sawada, Kazuhiro Takeuchi, Kyoko Wakamatsu, Arimi Ishikawa, Naomi Kuwahara, Yurika Sawa, Saeko Hatanaka, Kana Kokubo, Kosho Makino, Hideyo Takahashi, Yoko Endo, Shinobu Kunugi, Mika Terasaki, Yasuhiro Terasaki, Kouji Matsushima, Yuya Terashima, Akira Shimizu

    Kidney international   102 ( 6 )   1276 - 1290   2022.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Activated monocytes/macrophages promote glomerular injury, including crescent formation, in anti-glomerular basement membrane (GBM) glomerulonephritis. Disulfiram, an alcohol-aversion drug, inhibits monocyte/macrophage migration by inhibiting FROUNT, a cytosolic protein that enhances chemokine receptor signaling. Our study found that disulfiram at a human equivalent dose successfully blocked albuminuria and crescent formation with podocyte loss, and later stage kidney fibrotic lesions, in a rat model of anti-GBM glomerulonephritis. A disulfiram derivative, DSF-41, with more potent FROUNT inhibition activity, inhibited glomerulonephritis at a lower dose than disulfiram. Disulfiram markedly reduced the number of monocytes or macrophages at the early stage of glomerulonephritis and that of CD3+ and CD8+ lymphocytes at the established stage. Impaired pseudopodia formation was observed in the glomerular monocytes/macrophages of the disulfiram group; consistent with the in vitro observation that disulfiram blocked chemokine-dependent pseudopodia formation and chemotaxis of bone marrow-derived monocytes/macrophages. Furthermore, disulfiram suppressed macrophage activation as revealed by reduced expression of inflammatory cytokines and chemokines (TNF-α, CCL2, and CXCL9) and reduced CD86 and MHC class II expressions in monocytes/macrophages during glomerulonephritis. The dramatic reduction in monocyte/macrophage number might have resulted from disulfiram suppression of both the chemotactic response of monocytes/macrophages and their subsequent activation to produce cytokines and chemokines, which further recruit monocytes. Additionally, FROUNT was expressed in CD68+ monocytes/macrophages infiltrating the crescentic glomeruli in human anti-GBM glomerulonephritis. Thus, disulfiram can be a highly effective and safe drug for the treatment of glomerulonephritis by blocking the chemotactic responses of monocytes/macrophages and their activation status in the glomerulus.

    DOI: 10.1016/j.kint.2022.07.031

    PubMed

    researchmap

  • Malignant granular cell tumors: Combining cytological and pathological findings for a definitive diagnosis Reviewed

    Atsumi Enomoto, Mika Terasaki, Yukihiro Murase, Yasuyuki Kitagawa, Akira Shimizu, Ryuji Ohashi, Yasuhiro Terasaki

    Diagnostic Cytopathology   50 ( 8 )   E217 - E222   2022.4

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Abstract

    Malignant granular cell tumors (GCTs) account for less than 2% of all GCTs and mainly occur in the deep soft tissue of the thigh or trunk. Malignant GCTs are highly aggressive tumors with high rates of recurrence and metastasis. In this brief report, we describe a rare case of malignant GCT in a 64‐year‐old Japanese man who presented with a 14 × 20 cm mass in the left inguinal region. The cytologic findings of fine‐needle aspiration (FNA) revealed atypical epithelial‐like granular cells with granular substance in the background, which was difficult to differentiate from apocrine carcinoma or melanoma. The immunohistochemistry (IHC) findings of the needle biopsy revealed that the tumor cells were positive for S‐100 and lysosomal marker CD68 which was suggestive of a GCT. However, the presence of crush artifacts made it challenging to identify cellular atypia, which is a characteristic of malignant tumor. Taken together, the FNA and needle biopsy results were suggestive of malignant GCT. The importance of preoperative diagnosis of malignant GCT is well known, but few reports have described its cytological findings. In our brief report, we show that combining cytological FNA and biopsy findings with IHC findings achieves an accurate diagnosis of malignant GCT.

    DOI: 10.1002/dc.24970

    PubMed

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/dc.24970

  • Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL Reviewed

    Mika Terasaki, Yasuhiro Terasaki, Kyoko Wakamatsu, Naomi Kuwahara, Koichi Yoneyama, Rieko Kawase, Keisuke Kurose, Etsuko Toda, Yoko Endo, Shinobu Kunugi, Yusuke Kajimoto, Akira Shimizu

    Virchows Archiv   478 ( 5 )   893 - 904   2021.1

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1007/s00428-020-02996-1

    PubMed

    researchmap

    Other Link: https://link.springer.com/article/10.1007/s00428-020-02996-1/fulltext.html

  • Effect of H2 treatment in a mouse model of rheumatoid arthritis-associated interstitial lung disease. Reviewed International journal

    Yasuhiro Terasaki, Mika Terasaki, Satoshi Kanazawa, Nariaki Kokuho, Hirokazu Urushiyama, Yusuke Kajimoto, Shinobu Kunugi, Motoyo Maruyama, Toshio Akimoto, Yoko Miura, Tsutomu Igarashi, Ikuroh Ohsawa, Akira Shimizu

    Journal of cellular and molecular medicine   23 ( 10 )   7043 - 7053   2019.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), a primary cause of mortality in patients with RA, has limited treatment options. A previously established RA model in D1CC transgenic mice aberrantly expressed major histocompatibility complex class II genes in joints, developing collagen II-induced polyarthritis and anti-cyclic citrullinated peptide antibodies and interstitial pneumonitis, similar to those in humans. Molecular hydrogen (H2 ) is an efficient antioxidant that permeates cell membranes and alleviates the reactive oxygen species-induced injury implicated in RA pathogenesis. We used D1CC mice to analyse chronic lung fibrosis development and evaluate H2 treatment effects. We injected D1CC mice with type II collagen and supplied them with H2 -rich or control water until analysis. Increased serum surfactant protein D values and lung densities images were observed 10 months after injection. Inflammation was patchy within the perilymphatic stromal area, with increased 8-hydroxy-2'-deoxyguanosine-positive cell numbers and tumour necrosis factor-α, BAX, transforming growth factor-β, interleukin-6 and soluble collagen levels in the lungs. Inflammatory and fibrotic changes developed diffusely within the perilymphatic stromal area, as observed in humans. H2 treatment decreased these effects in the lungs. Thus, this model is valuable for studying the effects of H2 treatment and chronic interstitial pneumonia pathophysiology in humans. H2 appears to protect against RA-ILD by alleviating oxidative stress.

    DOI: 10.1111/jcmm.14603

    PubMed

    researchmap

  • A sarcomatoid localized malignant mesothelioma with ostesarcomatous elements Reviewed

    Mika Terasaki, Yasuhiro Terasaki, Mikiko Takahashi, Nariaki Kokuho, Shinobu Kunugi, Jitsuo Usuda, Akira Shimizu

    Human Pathology: Case Reports   14   16 - 19   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier Inc  

    DOI: 10.1016/j.ehpc.2018.06.003

    Scopus

    researchmap

    Other Link: http://orcid.org/0000-0003-0913-8279

  • Endometrioid carcinoma arising in a uterine adenomyoma Reviewed

    Mika Terasaki, Yasuhiro Terasaki, Rieko Kawase, Akira Shimizu

    Human Pathology: Case Reports   13   24 - 26   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier Inc  

    DOI: 10.1016/j.ehpc.2018.04.002

    Scopus

    researchmap

    Other Link: http://orcid.org/0000-0003-0913-8279

  • Uterine leiomyosarcoma with osteoclast-like giant cells associated with high expression of receptor activator of nuclear factor kappa B ligand Reviewed

    Mika Terasaki, Yasuhiro Terasaki, Koichi Yoneyama, Naomi Kuwahara, Kyoko Wakamatsu, Kiyotaka Nagahama, Shinobu Kunugi, Toshiyuki Takeshita, Akira Shimizu

    HUMAN PATHOLOGY   46 ( 11 )   1679 - 1684   2015.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:W B SAUNDERS CO-ELSEVIER INC  

    The occurrence of osteoclast-like giant cells (OLGCs) in uterine leiomyosarcomas (LMSs) is a rare phenomenon. The nature of OLGCs and the significance of their accumulation in these tumors are poorly understood. Recent studies revealed that the formation of osteoclasts requires a specific cytokine, receptor activator of nuclear factor kappa B ligand (RANKL), in bone. In this study, we investigated the expression of RANKL in 2 cases of uterine LMS with OLGCs by means of immunohistochemistry and compared the extent of RANKL expression with that in conventional uterine LMSs and leiomyomas by using real-time reverse-transcription quantitative polymerase chain reaction. Our cases of uterine LMS with OLGCs showed markedly high expression of RANKL messenger RNA with clear RANKL immunoreactivity compared with messenger RNA expression and immunoreactivity of conventional uterine LMSs and leiomyomas. These findings suggest that the tumors producing RANKL may account for accumulation of OLGCs in tumor tissue because of RANKL-related osteoclastogenesis. (C) 2015 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.humpath.2015.04.018

    Web of Science

    Scopus

    researchmap

    Other Link: http://orcid.org/0000-0003-0913-8279

  • Role of survivin in acute lung injury: epithelial cells of mice and humans Reviewed

    Yasuhiro Terasaki, Mika Terasaki, Hirokazu Urushiyama, Shinya Nagasaka, Mikiko Takahashi, Shinobu Kunugi, Arimi Ishikawa, Kyoko Wakamatsu, Naomi Kuwahara, Koichi Miyake, Yuh Fukuda

    LABORATORY INVESTIGATION   93 ( 10 )   1147 - 1163   2013.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Survivin, an inhibitor of apoptosis, regulates cell division and is a potential target for anticancer drugs because many cancers express high survivin levels. However, whether survivin would be toxic to human lung cells and tissues has not been determined. This report clarified the involvement of survivin in acute lung injury. We used immunohistochemical analysis, immunoelectron microscopy, and real-time reverse transcription-quantitative polymerase chain reaction to study survivin expression and localization in injured mouse and human lungs. We also used cultured human lung epithelial cells (BEAS-2B and A549) to study survivin cytoprotection. Nuclei and cytoplasm of epithelial cells in day 3 and day 7 models of bleomycin-injured lung showed survivin-positive results, which is consistent with upregulated survivin nnRNA expression. These nuclei also evidenced double positive findings for proliferating cell nuclear antigen and survivin. Day 7 models had similar Smac/DIABLO-positive and survivin-positive cell distributions. The cytoplasm and nuclei of epithelial cells in lesions with diffuse alveolar damage manifested strong survivin-positive findings. Bleomycin stimulation in both epithelial cell lines upregulated expression of survivin and apoptosis-related molecules. Suppression of survivin expression with small interfering RNA rendered human lung epithelial cells susceptible to bleomycin-induced damage, with markedly upregulated activation of caspase-3, caspase-7, poly (ADP-ribose) polymerase, and lactate dehydrogenase activity and an increased number of dead cells compared with mock small interfering RNA-treated cells. Overexpression of survivin via transfection resulted in these epithelial cells being resistant to bleomycin-induced cell damage, with reduced activation of apoptosis-related molecules and lactate dehydrogenase activity and fewer dead cells compared with results for mock-transfected cells. Survivin, acting at the epithelial cell level that depends partly on apoptosis inhibition, is therefore a key mediator of cytoprotection in acute lung injury. Understanding the precise role of survivin in normal lung cells is required for the development of therapeutic survivin.

    DOI: 10.1038/labinvest.2013.103

    Web of Science

    Scopus

    researchmap

    Other Link: http://orcid.org/0000-0003-0913-8279

  • A mucin-rich variant of salivary duct carcinoma with a prominent mucinous component, a tumor that mimics mucinous adenocarcinoma Reviewed

    Mika Terasaki, Yasuhiro Terasaki, Kyoko Wakamatsu, Mikiko Takahashi, Shinobu Kunugi, Hirokazu Urushiyama, Atsuko Sakanushi, Kimihiro Okubo, Yuh Fukuda

    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY   116 ( 3 )   E210 - E214   2013.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE INC  

    The mucin-rich variant of salivary duct carcinoma (mSDC) is a rare type of salivary duct carcinoma. mSDC usually has both conventional SDC and mucinous adenocarcinoma-like areas. This article describes a first case of mSDC in which 95% of the tumor consisted of a mucinous area without no solid conventional SDC, so that the tumor mimicked mucinous adenocarcinoma. A 55-year-old man was evaluated for a 14 mm mass in the left submandibular gland. The tumor showed that floating tumor nests in a prominent mucinous lake. Some floating tumor nests had focal cribriform pattern with comedo necrosis, and all tumor cells had immunoreactivity for androgen receptor, gross cystic disease fluid protein 15, and Her-2/neu. A diagnosis of mSDC was rendered. mSDC with prominent mucinous component sometimes resembles mucinous adenocarcinoma. Identifying specific histological and immunohistochemical features of floating tumor nests in the mucinous area are important for the diagnosis.

    DOI: 10.1016/j.oooo.2013.01.002

    Web of Science

    Scopus

    researchmap

    Other Link: http://orcid.org/0000-0003-0913-8279

  • Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process Reviewed

    Mika Yoshimatsu, Yasuhiro Terasaki, Naomi Sakashita, Emi Kiyota, Hiroo Sato, Luc J. W. Van Der Laan, Motohiro Takeya

    International Journal of Experimental Pathology   85 ( 6 )   335 - 343   2004.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Nonalcoholic steatohepatitis (NASH) is one of the life-threatening hepatic diseases
    however, its pathogenesis is still unknown. To evaluate the causative role of hyperlipidaemia and high-fat diet, we compared C57BL/6 mice with inherited hyperlipidaemic model mice (LDLR-/- mice and ApoE -/- mice) fed a normal or a high-fat diet. LDLR-/- and ApoE-/- mice fed the normal diet showed significantly higher serum cholesterol level than that of C57BL/6 mice fed the high-fat diet. These mice, however, have shown neither significant elevation of serum alanine transaminase (ALT) level nor histopathologic features of steatohepatitis. High-fat diet groups of all three strains showed histopathological characteristics of steatohepatitis with elevated serum ALT levels and high expression of macrophage scavenger receptor MARCO mRNA in the liver. Semi-quantitative endotoxin analysis showed an elevated serum endotoxin level in the portal vein but not in the vena cava in ApoE-/- mice fed the high-fat diet. These results indicate that long-term feeding of a high-fat diet induces NASH, whereas hyperlipidaemia alone is not enough to induce NASH. Liver-restricted induction of MARCO in mice with high-fat diet and portal endotoxaemia in ApoE -/- mice fed the high-fat diet suggest the possible involvement of endotoxin in the pathogenesis of NASH.

    DOI: 10.1111/j.0959-9673.2004.00401.x

    Scopus

    PubMed

    researchmap

    Other Link: http://orcid.org/0000-0003-0913-8279

  • Anti-N-methyl-d-aspartate Receptor Encephalitis Caused by a Teratoma Arising From the Retroperitoneum.

    Serika Yamamoto, Kentaro Suzuki, Jun Shioda, Shunsuke Kido, Mariko Terakado, Seira Hatake, Akihito Kutsuna, Tomonari Saito, Naofumi Okuda, Masafumi Toyoshima, Mika Terasaki, Hiroshi Nagayama, Kazumi Kimura

    Internal medicine (Tokyo, Japan)   64 ( 7 )   1097 - 1100   2025

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is an autoimmune encephalitis, and 46% of women with anti-NMDAR encephalitis have tumors, of which 94% are ovarian teratomas. Patients with anti-NMDAR encephalitis rarely have extra-ovarian teratomas, particularly extra-ovarian mature cystic teratomas arising from the retroperitoneum. We herein report a 27-year-old woman who was diagnosed with anti-NMDAR encephalitis caused by a teratoma arising from the retroperitoneum. In patients with anti-NMDAR encephalitis, it is important to perform a systemic search, including for extra-ovarian teratomas. Plasma exchange significantly improved the patient's clinical symptoms.

    DOI: 10.2169/internalmedicine.4028-24

    PubMed

    researchmap

  • Perirenal fat stranding as a predictor of disease progression after radical nephroureterectomy for renal pelvic urothelial carcinoma: a retrospective study. Reviewed International journal

    Masato Yanagi, Mika Terasaki, Tomonari Kiriyama, Yasuhiro Terasaki, Jun Akatsuka, Yuki Endo, Taiji Nishimura, Akira Shimizu, Yukihiro Kondo

    Discover. Oncology   14 ( 1 )   122 - 122   2023.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: To investigate the impact of Perirenal fat stranding (PRFS) on progression after radical nephroureterectomy (RNU) for renal pelvic urothelial carcinoma (RPUC) without hydronephrosis and to reveal the pathological findings of PRFS. METHODS: Clinicopathological data, including computed tomography (CT) findings of the ipsilateral PRFS, were collected from the medical records of 56 patients treated with RNU for RPUC without hydronephrosis between 2011 and 2021 at our institution. PRFS on CT was classified as either low or high PRFS. The impact of PRFS on progression-free survival (PFS) after RNU was analyzed using the Kaplan-Meier method and log-rank test. In addition, specimens including sufficient perirenal fat from patients with low and with high PRFS were pathologically analyzed. Immunohistochemical analysis of CD68, CD163, CD3, and CD20 was also performed. RESULTS: Of the 56 patients, 31(55.4%) and 25 (44.6%) patients were classified as having low and high PRFS, respectively. Within a median follow-up of 40.6 months postoperatively, 11 (19.6%) patients showed disease progression. The Kaplan-Meier method and log-rank test revealed that patients with high PRFS had significantly lower PFS rates than those with low PRFS (3-year PFS 69.8% vs 93.3%; p = 0.0393). Pathological analysis revealed that high PRFS specimens (n = 3 patients) contained more fibrous strictures in perirenal fat than low PRFS specimens (n = 3 patients). In addition, M2 macrophages (CD163 +) infiltrating fibrous tissue in perirenal area were observed in all patients with high PRFS group. CONCLUSIONS: PRFS of RPUC without hydronephrosis consists of collagenous fibers with M2 macrophages. The presence of ipsilateral high PRFS might be a preoperative risk factor for progression after RNU for RPUC patients without hydronephrosis. Prospective studies with large cohorts are required in the future.

    DOI: 10.1007/s12672-023-00741-z

    PubMed

    researchmap

  • T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein–Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma Reviewed

    Yusuke Kajimoto, Yasuhiro Terasaki, Mika Terasaki, Shinobu Kunugi, Yugo Okabe, Satoshi Wakita, Koiti Inokuchi, Akira Shimizu

    Diagnostic Pathology   15 ( 1 )   2020.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Background

    Epstein–Barr virus (EBV) is associated with the pathogenesis of a variety of malignancies, most notably lymphomas. Especially in the background of immunodeficiency, such as primary immunodeficiency disorder (PID) and post-transplant lymphoproliferative disorder (PTLD), the role of EBV might be crucial. PIDs are rare heterogeneous diseases affecting the development and/or the function of the innate and adaptive immune system. Malignancy is the second-highest cause of death after infection, and lymphoma accounts for about half of malignancies. The most frequently reported lymphoma type is diffuse large B-cell lymphoma (DLBCL) and the incidence of T-cell lymphoma is rare. PTLDs are also rare serious lymphoid and/or plasmacytic proliferative disorders that occur after undergoing solid organ or hematopoietic stem cell transplantation (HSCT). In the context of HSCT, most reported PTLDs have occurred in patients who received allogenic HSCT, but only a few cases have been reported in autologous HSCT (AutoHSCT) recipients.

    Case presentation

    A 53-year-old female patient initially presented with enlargement of the left cervical lymph nodes and was diagnosed with EBV-positive DLBCL. She was treated with R-CHOP, R-ACES, and AutoHSCT and went into remission. Four years later, computed tomography results revealed multiple lung nodules and abnormal infiltration, and sustained and progressing hypogammaglobulinemia was observed. The pathological specimen of video-assisted thoracoscopic surgical lung biopsy demonstrated extensive invasion of lymphocytes with notable granuloma findings. Flow cytometric immunophenotyping analysis showed that lymphocytes were positive for CD3 and CD5; especially, CD3 was expressed in the cytoplasm. Southern blot analysis revealed rearrangements of the T-cell receptor Cβ1 gene. She was diagnosed with peripheral T-cell lymphoma, not otherwise specified, accompanied by notable granulomatous lesions.

    Conclusion

    Here, as a unique case of metachronous B-cell and T-cell lymphoma, we report a rare case of T-cell lymphoma that mainly affected the lungs with the presentation of notable granulomatous findings following AutoHSCT for EBV-positive DLBCL at the age of 53 years. These lung lesions of granulomatous T-cell lymphoma could be related to the underlying primary immunodeficiency background associated with sustained hypogammaglobulinemia.

    DOI: 10.1186/s13000-020-01038-3

    PubMed

    researchmap

    Other Link: https://link.springer.com/article/10.1186/s13000-020-01038-3/fulltext.html

  • Molecular hydrogen attenuates gefitinib-induced exacerbation of naphthalene-evoked acute lung injury through a reduction in oxidative stress and inflammation. Reviewed International journal

    Terasaki Y, Suzuki T, Tonaki K, Terasaki M, Kuwahara N, Ohsiro J, Iketani M, Takahashi M, Hamanoue M, Kajimoto Y, Hattori S, Kawaguchi H, Shimizu A, Ohsawa I

    Laboratory investigation; a journal of technical methods and pathology   99 ( 6 )   793 - 806   2019.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Although inhibition of epidermal growth factor receptor (EGFR)-mediated cell signaling by the EGFR tyrosine kinase inhibitor gefitinib is highly effective against advanced non-small cell lung cancer, this drug might promote severe acute interstitial pneumonia. We previously reported that molecular hydrogen (H2) acts as a therapeutic and preventive anti-oxidant. Here, we show that treatment with H2 effectively protects the lungs of mice from severe damage caused by oral administration of gefitinib after intraperitoneal injection of naphthalene, the toxicity of which is related to oxidative stress. Drinking H2-rich water ad libitum mitigated naphthalene/gefitinib-induced weight loss and significantly improved survival, which was associated with a decrease in lung inflammation and inflammatory cytokines in the bronchoalveolar lavage fluid. Naphthalene decreased glutathione in the lung, increased malondialdehyde in the plasma, and increased 4-hydroxy-2-nonenal production in airway cells, all of which were mitigated by H2-rich water, indicating that the H2-rich water reverses cellular damage to the bronchial wall caused by oxidative stress. Finally, treatment with H2 did not interfere with the anti-tumor effects of gefitinib on a lung cancer cell line in vitro or on tumor-bearing mice in vivo. These results indicate that H2-rich water has the potential to improve quality of life during gefitinib therapy by mitigating lung injury without impairing anti-tumor activity.

    DOI: 10.1038/s41374-019-0187-z

    PubMed

    researchmap

  • A Case Of Sarcomatoid Malignant Mesothelioma With Prominent Osteosarcomatous Element Of The Pleura: High Expression Of Receptor Activator Of Nuclear Factor Kb Ligand (rankl)

    M. Terasaki, Y. Terasaki, N. Kokuho, H. Urushiyama, K. Wakamatsu, S. Kunugi

    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE   193   2016

     More details

    Language:English   Publisher:AMER THORACIC SOC  

    Web of Science

    researchmap

  • DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 2 AS A NOVEL MARKER IN BLADDER CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY Reviewed

    Shunichiro Nomura, Yasutomo Suzuki, Jun Akatsuka, Ryo Takahashi, Mika Terasaki, Ryoji Kimata, Ichiro Matsuzawa, Tsutomu Hamasaki, Go Kimura, Akira Shimizu, Yukihiro Kondo

    JOURNAL OF UROLOGY   191 ( 4 )   E235 - E235   2014.4

     More details

    Language:English   Publisher:ELSEVIER SCIENCE INC  

    DOI: 10.1016/j.juro.2014.02.851

    Web of Science

    researchmap

  • Hydrogen-Supplemented Drinking Water Protects Against Naphthalene-Gefitinib Induced Lung Injury From Inflammation-Associated Oxidative Stress

    Y. Terasaki, T. Suzuki, I. Ohsawa, H. Urushiyama, M. Terasaki, M. Takahashi, S. Kunugi, N. Kuwahara, A. Ishikawa, N. Kokuho, A. Shimizu

    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE   189   2014

     More details

    Language:English   Publisher:AMER THORACIC SOC  

    Web of Science

    researchmap

  • Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysis Reviewed

    Shunichiro Nomura, Yasutomo Suzuki, Ryo Takahashi, Mika Terasaki, Ryoji Kimata, Tsutomu Hamasaki, Go Kimura, Akira Shimizu, Yukihiro Kondo

    BMC UROLOGY   13   2013.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMED CENTRAL LTD  

    Background: Neoadjuvant chemotherapy has been shown to have benefit in T1 high-grade or T2 bladder cancer. However, neoadjuvant chemotherapy fails in some patients. Careful patient selection for neoadjuvant chemotherapy is therefore needed. Several reports show that Snail is associated with resistance to chemotherapy. We hypothesized that Snail expression could predict survival in T1 high-grade and T2 bladder cancer patients treated with neoadjuvant chemotherapy.
    Methods: The participants were 44 patients with T1 high-grade and T2 bladder cancer receiving neoadjuvant chemotherapy. Immunohistochemical analysis was used to determine Snail expression in specimens of bladder cancer obtained by transurethral resection before neoadjuvant chemotherapy. The relationships between Snail expression and patients' outcomes were analyzed.
    Results: Snail expression was positive in 15 of the 44 patients (34.1%) and negative in 29 (65.9%). Disease-free survival was significantly shorter for the Snail-positive group than for the Snail-negative group (p = 0.014). In addition, disease-specific survival was also significantly shorter for the Snail-positive group than for the Snail-negative group (p = 0.039). In multivariate analysis, Snail expression level was identified as an independent prognostic factor for disease-specific survival (p = 0.020).
    Conclusions: The results indicate that Snail expression may predict poor outcome in T1 high-grade and T2 bladder cancer patients treated with neoadjuvant chemotherapy.

    DOI: 10.1186/1471-2490-13-73

    Web of Science

    Scopus

    researchmap

    Other Link: http://orcid.org/0000-0003-0913-8279

  • The difference of neovascularization in early intra-alveolar fibrosis between nonspecific interstitial pneumonia and usual interstitial pneumonia Reviewed

    Mikiko Takahashi, Shinobu Kunugi, Yasuhiro Terasaki, Mika Terasaki, Hirokazu Urushiyama, Naomi Kuwahara, Kyoko Wakamatsu, Tomoko Nakayama, Yuh Fukuda

    PATHOLOGY INTERNATIONAL   63 ( 5 )   237 - 244   2013.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY  

    Of the idiopathic interstitial pneumonias (IIPs), usual interstitial pneumonia (UIP) and diffuse alveolar damage (DAD) usually have poor prognoses. The prognoses of cryptogenic organizing pneumonia (COP) and nonspecific interstitial pneumonia (NSIP) are usually more favorable. Although several reports have described neovascularization in COP and UIP, this aspect of UIP has not been compared with NSIP. In this study, we evaluated neovascularization in intra-alveolar fibrotic lesion of cases of fibrosing NSIP (f-NSIP) (n = 26) and UIP (n = 25). In the f-NSIP group, a considerable degree of neovascularization was observed compared to the UIP group and bud type intra-alveolar fibrosis showed a greater degree of neovascularization compared to the mural-incorporation and obliterative types of intra-alveolar fibrosis. Real-time reverse transcription polymerase chain reaction revealed a significantly greater expression of VEGF-A mRNA in f-NSIP than in UIP. The expression of matrix metalloproteinase-2 (MMP-2) mRNA also showed significantly higher in f-NSIP than UIP. The greater VEGF-A and MMP-2 expression may play a role in the pathogenesis of neovascularization in early intra-alveolar fibrotic lesions in f-NSIP.

    DOI: 10.1111/pin.12058

    Web of Science

    Scopus

    researchmap

    Other Link: http://orcid.org/0000-0003-0913-8279

  • Pathology of acute exacerbation of idiopathic interstitial pneumonia Reviewed

    Yuh Fukuda, Hirokazu Urushiyama, Mika Terasaki, Mikiko Takahashi, Shinobu Kunugi, Yasuhiro Terasaki

    Japanese Journal of Chest Diseases   72 ( SUPPL. )   2013

     More details

    Publishing type:Research paper (scientific journal)  

    Scopus

    researchmap

  • 9年後に再発が認められたAtypical polypoid adenomyoma(APAM)の1例

    重見 大介, 田村 俊之, 佐藤 杏月, 松橋 智彦, 山本 晃人, 川瀬 里衣子, 黒瀬 圭輔, 米山 剛一, 鴨井 青龍, 竹下 俊行, 寺崎 美佳, 福田 悠

    日本医科大学医学会雑誌   8 ( 4 )   327 - 327   2012.12

     More details

    Language:Japanese   Publisher:日本医科大学医学会  

    researchmap

  • Clinico-pathological analysis of acute respiratory distress syndrome (ARDS) Reviewed

    Yuh Fukuda, Mikiko Takahashi, Shinobu Kunugi, Mika Terasaki, Hirokazu Urushiyama, Yasuhiro Terasaki, Arata Azuma

    EUROPEAN RESPIRATORY JOURNAL   40   2012.9

     More details

    Language:English   Publisher:EUROPEAN RESPIRATORY SOC JOURNALS LTD  

    Web of Science

    researchmap

  • A Neuroendocrine Carcinoma from a Difficult-to-detect Primary Site Presenting as Neck and Mediastinal Lymphadenopathy

    Miura Yukiko, Minegishi Yuji, Saito Yoshinobu, Terasaki Mika, Fukuda Yu, Gemma Akihiko

    Nihon Ika Daigaku Igakkai Zasshi   8 ( 2 )   162 - 167   2012

     More details

    Language:Japanese   Publisher:The Medical Association of Nippon Medical School  

    An 83-year-old man presented with supraclavicular and mediastinal lymph nodes swelling and elevated serum levels of neuron-specific enolase (NSE), pro-gastrin-releasing peptide (pro-GRP), and cytokeratin fragment (CYFRA). He underwent supraclavicular lymph node dissection. The pathological diagnosis was metastatic lymph node neuroendocrine carcinoma. The initial diagnosis was small cell lung carcinoma c-TxN3M0 III B with an unknown primary site, because fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-PET) had revealed increased uptake in the neck and mediastinal lymphadenopathy, but no significant intrapulmonary uptake. However, computed tomography (CT) of the chest had detected a lesion, which was assumed to be a vessel, in the right lower lung. The patient underwent radiotherapy, and CT of the chest 1 month later revealed a partial response of the lymph nodes. However, at the same time, disease recurred in the skin adjacent to the site of supraclavicular lymph node dissection, and the lesion in the right lower lung enlarged. We suspected that this intrapulmonary lesion was the primary site. Metastasis to cervical and mediastinal lymph nodes from an unknown primary carcinoma is rare, and the primary site should be determined so that appropriate treatment can be performed. If the primary site cannot be determined with the initial examination, regular follow-up examinations with CT, magnetic resonance imaging, and FDG-PET should be performed.<br>

    DOI: 10.1272/manms.8.162

    researchmap

  • Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress Reviewed

    Yasuhiro Terasaki, Ikuroh Ohsawa, Mika Terasaki, Mikiko Takahashi, Shinobu Kunugi, Kang Dedong, Hirokazu Urushiyama, Shunsuke Amenomori, Mayuko Kaneko-Togashi, Naomi Kuwahara, Arimi Ishikawa, Naomi Kamimura, Shigeo Ohta, Yuh Fukuda

    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY   301 ( 4 )   L415 - L426   2011.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER PHYSIOLOGICAL SOC  

    Terasaki Y, Ohsawa I, Terasaki M, Takahashi M, Kunugi S, Dedong K, Urushiyama H, Amenomori S, Kaneko-Togashi M, Kuwahara N, Ishikawa A, Kamimura N, Ohta S, Fukuda Y. Hydrogen therapy attenuates irradiation-induced lung damage by reducing oxidative stress. Am J Physiol Lung Cell Mol Physiol 301: L415-L426, 2011. First published July 15, 2011; doi: 10.1152/ajplung.00008.2011.-Molecular hydrogen (H-2) is an efficient antioxidant that diffuses rapidly across cell membranes, reduces reactive oxygen species (ROS), such as hydroxyl radicals and peroxynitrite, and suppresses oxidative stress-induced injury in several organs. ROS have been implicated in radiation-induced damage to lungs. Because prompt elimination of irradiation-induced ROS should protect lung tissue from damaging effects of irradiation, we investigated the possibility that H-2 could serve as a radioprotector in the lung. Cells of the human lung epithelial cell line A549 received 10 Gy irradiation with or without H-2 treatment via H-2-rich PBS or medium. We studied the possible radioprotective effects of H-2 by analyzing ROS and cell damage. Also, C57BL/6J female mice received 15 Gy irradiation to the thorax. Treatment groups inhaled 3% H-2 gas and drank H-2-enriched water. We evaluated acute and late-irradiation lung damage after H-2 treatment. H-2 reduced the amount of irradiation-induced ROS in A549 cells, as shown by electron spin resonance and fluorescent indicator signals. H-2 also reduced cell damage, measured as levels of oxidative stress and apoptotic markers, and improved cell viability. Within 1 wk after whole thorax irradiation, immunohistochemistry and immunoblotting showed that H-2 treatment reduced oxidative stress and apoptosis, measures of acute damage, in the lungs of mice. At 5 mo after irradiation, chest computed tomography, Ashcroft scores, and type III collagen deposition demonstrated that H-2 treatment reduced lung fibrosis (late damage). This study thus demonstrated that H-2 treatment is valuable for protection against irradiation lung damage with no known toxicity.

    DOI: 10.1152/ajplung.00008.2011

    Web of Science

    Scopus

    researchmap

    Other Link: http://orcid.org/0000-0003-0913-8279

  • Induction of macrophage receptor with collagenous structure (MARCO) suggests possible involvement of endotoxin in nonalcoholic steatohepatitis (NASH)

    M. Takeya, M. Terasaki, Y. Terasaki, N. Sakashita, H. Sato

    ATHEROSCLEROSIS SUPPLEMENTS   7 ( 3 )   409 - 409   2006.6

     More details

    Language:English   Publisher:ELSEVIER IRELAND LTD  

    Web of Science

    researchmap

  • 骨盤腔に発生したextrathoracic solitary fibrous tumorの1例

    吉松 美佳, 山田 保俊, 竹屋 元裕

    診断病理   19 ( 3 )   266 - 268   2002.7

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    58歳男.検診の腹部エコーで骨盤内腫瘤を指摘され,骨盤部MRIで,膀胱左後方に骨盤腔を占拠する腫瘍性病変を認めたため,摘出術を施行した.腫瘍は膀胱頸周囲の軟部組織内にあり,恥骨後面と強固な癒着がみられたが,膀胱・直腸・前立腺との連続性はなかった.腫瘍は境界明瞭で,大部分充実性で,内部に大小の結節形成がみられ,辺縁は嚢胞状で,出血を一部認めたが壊死はみられなかった.腫瘍内結節部では類円形から紡錘形の比較的揃った核を有する腫瘍細胞が,アザン染色に青染する放射状のコラーゲン線維形成を伴って増殖していた.結節部周辺の腫瘍組織では細胞成分に乏しい浮腫状間質を示す部位がみられ,硝子化した血管や星芒状の核を示す腫瘍細胞が散見された.組織学的所見,免疫組織化学所見等より骨盤腔に発生したextrathoracic solitary fibrous tumorと診断した

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2002&ichushi_jid=J03623&link_issn=&doc_id=20020812410024&doc_link_id=%2Fcd9jjodp%2F2002%2F001903%2F024%2F0266-0268%26dl%3D0&url=http%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fcd9jjodp%2F2002%2F001903%2F024%2F0266-0268%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

  • 上唇小唾液腺より発生したcanalicular adenomaの1例

    吉松 美佳, 楠川 仁悟, 豊福 士文, 河野 真司

    診断病理   19 ( 1 )   15 - 17   2002.1

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    80歳男.約5年前よりの右上唇腫瘤の増大を主訴とした.腫瘍は小指頭大,弾性軟,可動性良好で,上部を覆う正常粘膜とともに摘出された.粘膜下に存在する大きさ9×7mm の境界明瞭な腫瘍で,組織学的にcanalicular adenomaに特徴的な二列の円柱上皮のビーズ状配列と浮腫状の間質が認められた.腫瘍に近接した小唾液腺内にcanalicular adenomaの腫瘍細胞形態と類似した小病巣と考えられる部位を認めた.multifocal canalicular adenomaの可能性も考え,再発に注意すべきであると考えられた

    researchmap

  • The Role of Macrophage Scavenger Receptors in Atherogenesis Reviewed International journal

    Mika Terasaki

    Atherosclerosis and Autoimmunity   29 - 40   2001

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier  

    DOI: 10.1016/b978-044450669-6/50005-0

    researchmap

▼display all

Misc.

  • 腎臓病理画像における深層学習を用いた糸球体およびメサンギウム領域の自動検出

    宮川 諒, 寺崎 美佳, 高熊 将一朗, 功刀 しのぶ, 清水 章, 遠田 悦子, 寺崎 泰弘

    日本医科大学医学会雑誌   21 ( 4 )   376 - 376   2025.12

     More details

    Language:Japanese   Publisher:日本医科大学医学会  

    researchmap

  • 腎臓病理画像における深層学習を用いた糸球体の自動検出 QuPathへの統合と応用の可能性

    宮川 諒, 寺崎 美佳, 遠田 悦子, 澤 百合香, 寺崎 泰弘, 高熊 将一朗, 功刀 しのぶ, 清水 章

    日本病理学会会誌   114 ( 1 )   461 - 461   2025.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 説明可能AIによる子宮内膜細胞診のリアルタイム支援 顕微鏡下でのスタンドアローン診断システム開発

    河村 拓実, 寺崎 美佳, 今枝 俊輔, 木原 康生, 寺崎 泰弘, 遠田 悦子, 高熊 将一朗, 功刀 しのぶ, 清水 章, 鈴木 寿

    日本病理学会会誌   114 ( 1 )   437 - 437   2025.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 子宮内膜細胞診における厚み情報の3D表示システムの開発 立体構造の視覚的把握を支援する新ツール

    木原 康生, 寺崎 美佳, 今枝 俊輔, 河村 拓実, 寺崎 泰弘, 遠田 悦子, 高熊 将一朗, 功刀 しのぶ, 清水 章, 鈴木 寿

    日本病理学会会誌   114 ( 1 )   437 - 438   2025.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 子宮内膜細胞診の厚み情報を反映した明度分布の特性関数に基づく異常細胞集塊自動検出(Automated Detection of Abnormal Cell Clusters Based on Brightness and Thickness Characteristics in Endometrial Cytology)

    寺崎 美佳, 今枝 俊輔, 木原 康生, 河村 拓, 寺崎 泰弘, 遠田 悦子, 清水 章, 鈴木 実寿

    日本病理学会会誌   113 ( 2 )   114 - 114   2024.10

     More details

    Language:English   Publisher:(一社)日本病理学会  

    researchmap

  • AI子宮内膜細胞診モデルの診断根拠可視化と診断者の難易度評価による臨床応用性の検証

    下川 一燈, 田中 俊, 寺崎 美佳, 遠田 悦子, 寺崎 泰弘, 高熊 将一郎, 清水 章

    日本臨床細胞学会雑誌   63 ( Suppl.2 )   623 - 623   2024.10

     More details

    Language:Japanese   Publisher:(公社)日本臨床細胞学会  

    researchmap

  • 顕微鏡動画の即時的物体検出(real-time object detection)を用いたAI子宮内膜細胞診断サポートモデル開発

    田中 俊, 下川 一燈, 寺崎 美佳, 田畑 諒, 遠田 悦子, 寺崎 泰弘, 高熊 将一朗, 清水 章

    日本病理学会会誌   113 ( 1 )   479 - 480   2024.2

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 顕微鏡動画の即時的物体検出(real-time object detection)を用いたAI子宮内膜細胞診サポートモデル開発

    下川 一燈, 田中 俊, 遠田 悦子, 高熊 将一郎, 清水 章, 寺崎 美佳, 寺崎 泰弘

    日本医科大学医学会雑誌   19 ( 4 )   380 - 380   2023.12

     More details

    Language:Japanese   Publisher:日本医科大学医学会  

    researchmap

▼display all

Presentations

  • AIは細胞診をどう変えるか:開発経験から見えた深層学習のリスクと制御の必要性 Invited

    寺崎美佳

    第67回日本臨床細胞学会総会(春期大会)(横浜)  2026.6 

     More details

    Event date: 2026.6

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Venue:横浜  

    researchmap

  • 細胞診断とAI~基礎から将来展望~ 医療者が知っておきたい人工知能の基礎 Invited

    寺崎 美佳

    第64回日本臨床細胞学会秋期大会(広島市)  2025.11  広島大学

     More details

    Event date: 2025.11

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Venue:広島国際会議場・広島市文化交流会館  

    シン・細胞診
    「細胞検査士会要望教育シンポジウム 細胞診断とAI 〜基礎から将来展望〜

    researchmap

  • AI Bridging Pathology and Clinical Practice Development of Real-Time AI-Assisted Devices for Microscopic Diagnosis and Educational Initiatives Invited

    Mika Terasaki

    2025.4  (一社)日本病理学会

     More details

    Event date: 2025.4

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    researchmap

  • Development of an AI Real-time Object Detection System in Endometrial Cytology

    2024.3  (一社)日本病理学会

     More details

    Event date: 2024.3

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • Microscope to AI リアルタイム内膜細胞診支援AI開発 〜医療者が知っておきたいAIの基本〜 Invited

    寺崎美佳

    令和6年度子宮がん検診従事者講習会(福岡地区)  2025.3 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 医療者が知っておきたいAIの基本

    寺崎美佳

    日本医科大学オープンキャンパス  2025.8 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 医療とAI 〜 病理診断支援AI開発からみえてきたもの 〜 Invited

    寺崎美佳

    洗足学園中学高等学校  2025.9 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 知っておきたいAIのキホン Invited

    寺崎美佳

    日本医科大学ダイバーシティ研究環境実現イニシアティブ リサーチカフェ  2025.12 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

  • 医療者が知っておきたいAIの基本 Invited

    寺崎美佳

    日本医科大学父母会懇親会講演会  2026.5 

     More details

    Language:Japanese   Presentation type:Public lecture, seminar, tutorial, course, or other speech  

    researchmap

▼display all

Awards

  • 優秀演題賞

    2025.9   第93回 日本医科大学医学会総会・学術集会   腎臓病理画像における深層学習を用いた 糸球体およびメサンギウム領域の自動検出

    宮川諒 寺崎美佳 遠田悦子 寺崎泰弘 高熊将一朗 功刀しのぶ 清水章

     More details

  • 優秀演題賞

    2025.3   日本病理学会   腎臓病理画像における深層学習を用いた糸球体の自動検出

    宮川諒, 寺崎美佳, 河村拓実, 遠田悦子, 寺崎泰弘, 清水章

     More details

  • 優秀演題賞

    2023.9   第91回日本医科大学医学会総会・学術集会   顕微鏡動画の即時的物体検出(real-time object detection)を用いたAI子宮内膜細胞診断サポートモデル開発

    下川一燈, 田中峻, 寺崎美佳

     More details

  • JMAI AWARD 2022

    2022.7  

    Mika Terasaki

     More details

Research Projects

  • 人工知能を用いた術前子宮体癌検出のための新規病理診断サポートモデルの開発

    Grant number:23K08900  2023.4 - 2026.3

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    寺崎 美佳, 遠田 悦子, 高熊 将一朗, 寺崎 泰弘

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    researchmap

  • 子宮肉腫におけるターゲット因子抑制とその応用

    Grant number:20K09680  2020.4 - 2023.3

    日本学術振興会  科学研究費助成事業 基盤研究 (C) 2020-2023  基盤研究(C)

    寺崎 美佳, 遠田悦子, 寺崎泰弘

      More details

    Authorship:Principal investigator 

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    子宮平滑筋肉腫は多彩な組織像を示すが、形態の違いに基づく治療選択は行われておらず、治療に直結する有効な治療法の開発が急務となっている。私たちは、 破骨細胞型巨細胞を伴う子宮平滑筋肉腫において、骨の破骨細胞形成に必須のサイトカイン(RANKL)を産生していることを発見した。また腫瘍細胞に骨芽細胞化を誘導する転写因子RUNX2の高発現を認めた。 RUNX2は近年、前立腺癌や腎癌、肺癌において予後不良因子としての報告がみられる。RUNX2とRANKLの発現局在の検討から、腫瘍細胞の多くはRUNX2を発現し、その 一部がRANKLを発現していることが明らかとなった。また腫瘍内マクロファージおよび破骨型巨細胞では、RANKL受容体や破骨細胞分化に必須の転写因子NFATc1の発現がみられ、骨吸収に関与するコラーゲン分解酵素であるCathepsin Kの強発現がみられた。これらの結果を英文紙に発表した(Virchows Archiv, 2021)。また腫瘍の骨芽細胞化は、癌の脱分化や上皮間葉転換に関わる可能性が想定されたため、様々な臓器に横断的にみられる現象である可能性を考え、他臓器脱分化癌を中心に、RUNX2等の発現について検討し、同様の結果がみられる傾向にある。

    researchmap

  • 子宮平滑筋肉腫におけるターゲット因子の同定とその応用

    Grant number:17K11299  2017.4 - 2020.3

    日本学術振興会  科学研究費助成事業 基盤研究(C) 2017-2020  基盤研究(C)

    寺崎 美佳, 寺崎 泰弘, 永坂 真也

      More details

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    子宮平滑筋肉腫は、多彩な組織像を示すが、形態の違いにもとづく治療選択は行われておらず、治療に直結する診断法、有効な治療法の開発が急務となっている。私たちは、破骨細胞型巨細胞を伴う子宮平滑筋肉腫では、骨破骨細胞形成に必須のサイトカイン(RANKL)を産生していることを発見し、形態の違いが腫瘍発現因子の違いにつながるという発想のもと、RANKLを中心とした腫瘍増殖の機序を解明を目的として研究を行っている。
    RANKL発現を制御する上流因子候補を(分子間ネットワーク/パスウェイ解析データベースインジェヌイティーパスウェイアナリシス(IPA)をし、CXCL-13, TNFα, IL-6などについてqPCRで検討したが、いずれも腫瘍細胞に発現上昇は見られなかった。腫瘍が骨芽細胞化している可能性を念頭に、骨芽細胞化マーカーを発現について解析継続中である。現在ヒト平滑筋培養細胞にRANKLを持続発現する培養細胞を作成し、腫瘍増殖因子や単球からの破骨細胞分化について検討を進めている。
    また同様の組織型を示す腫瘍を全身臓器から広く検索し、それぞれの腫瘍におけるRANKL発現を検討した。いずれもRANKL mRNAおよび蛋白発現上昇を認めており、他臓器でも同様の腫瘍発生機構が存在する可能性が示唆された。またRANKL発現上昇が組織形態に影響を与えている可能性を考え、現在他臓器腫瘍でもRANKL局在などについて検討中である。

    researchmap

  • Elucidation of molecular mechanism of survivin in inflammatory lung disease and development of new gene therapy method

    Grant number:26461203  2014.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Terasaki Mika

      More details

    Grant amount:\4940000 ( Direct Cost: \3800000 、 Indirect Cost:\1140000 )

    Survivin is a protein having two roles of cell proliferation and apoptosis inhibiting function, and focused on the pathology of interstitial pneumonia and analyzed the mechanism of action of this factor. In human and model mice of interstitial pneumonia disease, high expression of survivin was observed mainly in the regenerating alveolar epithelium. Even in cultured cells, similar expression increase was observed by induction of injury, and suppression of survivin remarkably inhibited cell proliferation. Since survivin expression is observed in the regenerating epithelium in various injuries regardless of the cause, it became clear that survivin is indispensable for regeneration upon cell injury.

    researchmap

  • Biomarker Profiling of Interstitial Pneumonia Based on Transitional State Cells

    Grant number:25K11487  2025.4 - 2028.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    researchmap

  • Identification of disease-specific proteins in glomerular diseases and renal deposition diseases by mass spectrometry using renal biopsy specimens

    Grant number:23K07710  2023.4 - 2026.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    researchmap

  • 多様なリンパ球増殖性肺病変の局所リンパ球のプロファイリングとバイオマーカー開発

    Grant number:20K08553  2020.4 - 2023.3

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    寺崎 泰弘, 寺崎 美佳, 遠田 悦子, 康 徳東

      More details

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    リンパ球増殖性肺病変の代表である、IgG4 関連疾患は臓器の腫大を特徴とし、高 IgG4 血症および組織中の IgG4 陽性細胞浸潤と線維化を認める疾患である。一方で呼吸器単独病変で血清 IgG4 高値、組織に IgG4 陽性細胞浸潤を伴う間質性肺炎の場合、鑑別に苦慮する。血清 IgG4 高値で、IgG4 陽性細胞浸潤を認めたびまん性肺病変の症例を全国から募り 17 施設より 29 例を集め解析した。臨床・画像・病理学的な検討( MDD )を行い、多中心性キャッスルマン病など鑑別疾患を除外して残った16 例を IgG4 陽性間質性肺炎(症候群)と診断した。診断時の年齢中央値は 66 歳、男性が 12 例であった。喫煙者は 13 例、呼吸器症状を有する症例は 13 例であった。画像検査・病理学的所見は多彩で、閉塞性血管炎を呈した症例は認めなかった。15 例がステロイドによる治療を受けた。全例のすりガラス影は改善したが、 6 例で網状影の増悪を認めた。 9 例では、網状影・嚢胞性病変の残存を認めた。2 例が慢性呼吸不全、 1 例が急性増悪のため死亡した。 IgG4 陽性間質性肺炎(症候群)は、ステロイド反応性が良好な IgG4 関連疾患とは異なる対応が必要であると考えられた。上記結果をERJ Open Res 2021; 7: 00317, 2021.に 報告掲載した。
    さらに IgG4 陽性間質性肺炎(症候群)を、IgG4関連呼吸器疾患(IgG4-RRD)として扱うのが適切かを検討した。IgG4 陽性間質性肺炎の多くがACR/EULAR 分類基準では特異抗体およびステロイド反応性不良のため除外された。 IgG4 関連呼吸器疾患診断基準においてもステロイド反応性について記載することを検討すべきである。IgG4 陽性間質性肺炎のすりガラス影はステロイドに対する反応性良好だが、一方で網状影・嚢胞性病変は残存・増悪し、急性増悪例や死亡例も認められる。IgG4 陽性間質性肺炎は、予後良好な IgG4 関連疾患と区別して管理する必要がある。

    researchmap

  • Biomarker development and clinical application by extraction of pathogenesis-related factors from early fibrosis foci of interstitial pneumonia

    Grant number:17K09630  2017.4 - 2020.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Terasaki Yasuhiro

      More details

    Authorship:Coinvestigator(s) 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    In the PPFE case, the elastic fibers of the alveolar septum remained, and newly formed elastic fibers were seen in the active fibrous lesion.In UIP cases, the elastic fibers in the alveolar septum tended to disappear, and cysts with fibrous remodeling with bronchiolization were formed, but there was no evidence of newly formed elastic fibers in the active fibrous lesion.Mass spectrometry analysis revealed increased levels of FBLN and LTBP2 iin the active fibrous lesion of PPFE, and immunostaining showed FBLN- and LTBP2-positive newly formed elastic fibers were often seen in the active fibrous lesion of PPPFE cases. FBLN levels in serum of 4 PPFE cases, 4 UIP cases, and 4 controls were very high only in PPFE cases, indicating its potential as a marker of hematologic disease in PPFE lesions.

    researchmap

  • MicroRNA and exosome in interstitial pneumonia

    Grant number:26461204  2014.4 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Kunugi Shinobu, MIYAKE KOUICHI, NAGASAKA SHINYA, TERASAKI MIKA, SEIKE MASAHIRO, ISHIKAWA ARIMI, KUWAHARA NAOMI

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    We performed micro RNA analysis of serum, bronchoalveolar lavage, and lung tissue of bleomycin-induced pneumonitis in mice. Particularly, We analyzed exosomal franction and others fraction of bronchoalveolar lavage.In fibrotic stage,the elevation of miR-150 were confirmed.

    researchmap

  • Analysis of lymphoplasmacyte infiltrating fibrotic lung lesion using samples from human lung diseases and RA lung model in D1CC mice

    Grant number:25461175  2013.4 - 2016.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    terasaki yasuhiro, MATSUI Shoko, TERASAKI Mika, MIYAKE Koichi, KANAZAWA Satoshi, KUNUGI Shinobu, OGURA Takashi

      More details

    Grant amount:\5070000 ( Direct Cost: \3900000 、 Indirect Cost:\1170000 )

    Although both lesions had lymphoplasmacyte infiltrated lesion, lung lesions of IgG4-related disease was characterized by active fibrosis with eosinophilic infiltration within lymphatic stroma itself with obstructive vasculitis, whereas lung lesion of idiopathic multicentric Castleman's disease was marked lymphoplasmacyte proliferating lesions mainly in the alveolar area adjacent to lymphatic stroma and sometimes conspicuous cyst formation. These clinicopathological features may help differentiate them and influence their prognoses.
    RA lung model in D1CC mice is very similar to RA lung in humans with inflammatory cells infiltration and alveolitis as lymphangiitic distribution and would be valuable model for investing general pathophysiology of chronic interstitial pneumonias in humans. H2 treatment protected the lung damage with reduction of the increased levels of serum SP-D, CT image density as well as histological changes, thus would be valuable for protection against RA induced lung.

    researchmap

  • Protection by hydrogen therapy against oxidative stress induced various lung diseases.

    Grant number:22590873  2010 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    TERASAKI Yasuhiro, OHSAWA Ikuro, FUKUDA Yuh, TERASAKI Mika

      More details

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    Various lung injuries such as irradiation or anticancer drug induced injuries are reportedly initiated and sustained by oxidative stress (reactive oxygen species:ROS), especially hydroxyl radicals (-OH), which are the primary cause of the damage. As yet,no ideal ROS scavenge therapy has been established. Because H2 was recently reported as an efficient antioxidant that diffuses rapidly across cell membranes, selectively reduces -OH, and suppresses oxidative stress-induced injury with no known toxicity, we studied the possibility that H2 could protect against irradiation or anticancer drug induced lung damage. We show here that H2 scavenged -OH and protected against apoptotic damage related to oxidative stress induced by irradiation and anticancer drug in lung epithelial cells and in lungs of mice. H2 treatment will thus be valuable for protection against oxidative stress induced various lung diseases.

    researchmap

  • Application of CD204 (scavenger receptor) to histopathological diagnosis and production of new anti-macrophage antibodies

    Grant number:16390108  2004 - 2007

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    TAKEYA Motohiro, SAKASHITA Naomi, KAIKITA Koichi

      More details

    Grant amount:\13700000 ( Direct Cost: \13700000 )

    Scavenger receptors possess wide-ranged ligand-binding specificities and are considered to be one of the pattern recognition receptors that play important roles in host defence. Among such receptors, CD204 (Class A scavenger receptor Type I and II) and CD163 (hemoglobin scavenger receptor) are expressed exclusively on macrophages and considered to be a good marker for macrophages in histopathology. Using self-made antibodies, we have shown that CD204 and CD163 are positive for resident macrophages and a population of inflammatory macrophages in paraffin sections. In granulomatous diseases such as tuberculosis and sarcoidosis, infiltrated macropages surrounding the granulomas were positive for CD204 and CD163, however multinucleated giant cells were negative or only weakly labeled. Since CD204 and CD163 are induced in alternatively activated macrophages, these antibodies are considered to be valuable tools to label such macrophage subpopulation in hitopathological specimens.
    In animal models of acute myocardial infarction and high-dose oxygen-induced lung injury, CD204-deficient mice showed exacerbation of disease process in both models. In myocardial infarction model, CD204-deficiency showed increased ratio of cardiac rupture with increased expression of TNF- a and enhanced activation of matrix metalloproteinases (MMP). In lung injury model, CD204-deficiency also showed higher expression of TNF- a and increased MMP activity. These results indicate that CD204-positive macrophages regulate inflammatory process by suppressing the excessive inflammatory responses.
    In the future experiments, such anti-inflammatory alternatively activated macrophages will be evaluated in various human diseases using self-made antibodies against CD204 and CD 163.

    researchmap

▼display all

Other research activities

Teaching Experience

  • Medical Informatics & Data Science II

    2024.6
    Institution:Nippon Medical School

     More details

  • 泌尿器病理各論

    2021
    Institution:日本医科大学

     More details

  • 婦人科腫瘍病理学

    2018
    Institution:日本医科大学

     More details

  • 婦人科病理各論 (日本医科大学)

    2017

     More details

  • 病理学総論

    2014
    Institution:日本医科大学

     More details